HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

CMS proposes permanent framework for Medicare drug price negotiations

The Trump administration is floating a proposal to establish a permanent framework for the Medicare drug price negotiations, as enabled by the Inflation Reduction Act (IRA).

By FiercePharma · Jun 14, 2026 · via FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
FDA hearing on Amgen's Tavneos will include findings from an independent review
An independent research firm is reviewing data on Amgen's Tavneos as the company prepares for a hearing with t…
Jun 14, 2026
Guardant Health nabs FDA test approval to find patients for Boehringer's new cancer drug
The WeekFierceBiotech ↗
Guardant Health nabs FDA test approval to find patients for Boehringer's new cancer drug
Boehringer Ingelheim's Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared …
Jun 14, 2026
Administration Moves to Tighten Medicare Drug Price Negotiation Rules
The WeekBriefing
Administration Moves to Tighten Medicare Drug Price Negotiation Rules
The Trump administration proposed changes aimed at closing a loophole in Medicare’s drug price negotiation fra…
Jun 14, 2026